RecruitingNCT04959175
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
PHASE1 · PHASE2 · 320 planned enrolment
- Countries listed
- 1
- Registry update
- October 8, 2026
